Project Grant R35GM161411
- Federal Project Grant Award Summary Indiana University received a $446,435 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 4, 2025, with completion targeted for June 30, 2029. The grant supports fundamental research into the mechanisms of pterin-dependent regulation in proteobacterial systems, specifically investigating how bacteria transition from free-living to biofilm...
- Federal Project Grant Award Summary Indiana University received a $428,857 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 15, 2026, with completion targeted for December 31, 2030. The award supports fundamental research investigating the mechanisms of cell dormancy and virus entrapment in spore-forming bacteria, specifically examining how certain viruses have evolved...
- Federal Project Grant Award Summary Indiana University Indianapolis received a $396,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through February 28, 2031. The award funds fundamental research to decode the structural and molecular architecture of centriolar plaques (CPs), non-centrosomal microtubule organizing centers involved in atypical eukaryotic cell...
- Federal Project Grant Award Summary Indiana University Indianapolis received a $435,875 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 9, 2025, with completion targeted for July 31, 2030. This award supports fundamental biomedical research investigating the coding and noncoding molecular mechanisms of a bifunctional gene across multiple cellular contexts. The...
- Federal Grant Award Summary Indiana University received a $631,989 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 5, 2025, through September 4, 2027. The award supports fundamental research into enantioselective chemical synthesis methods utilizing Lewis base and transition metal catalysis to develop efficient stereoselective reactions. The research objectives focus on...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $382,026 to Indiana University (Trustees of Indiana University) on September 15, 2025, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports a research initiative titled "Target-Specific Dyes with Responsive Long-Lived Fluorescence Lifetimes for Biological Interrogation," with performance through August 31, 2030. The project...
- Federal Grant Award Summary Indiana University Indianapolis has received a $772,026 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through June 30, 2030. The award supports the development and validation of improved methodologies for conducting in vivo forward genetic screening, a high-throughput functional genomics approach that has been successfully applied in...
- Federal Project Grant Award Summary Indiana University (Trustees of Indiana University) received a $370,783 Project Grant award on September 10, 2025, from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) to develop an intelligent droplet acoustofluidic platform for automated liquid-liquid handling and monitoring in biomedical research. The project, which runs through August 31, 2029, will integrate digital...
- Federal Project Grant Award Summary Purdue University received a $150,104 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 12, 2026, with a completion date of November 16, 2028. The grant supports fundamental research aimed at determining the role of CsoS2 protein in carboxysome assembly and regulation—a critical component of the carbon dioxide concentrating mechanism found in...
- Federal Grant Award Summary The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded $494,253 to Indiana University for a Project Grant (CFDA 47.041 - Engineering) beginning April 15, 2025, with completion targeted for March 31, 2028. The award supports structural and biophysical research on evolved Fe(II)/2-ketoglutarate-dependent azidases designed to expand enzymatic C-H (carbon-hydrogen) functionalization capabilities. The core...
Indiana University (Trustees of Indiana University) received a $415,822 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through February 28, 2031. The award supports fundamental basic research investigating oxidative protein folding mechanisms in bacteria, specifically examining how disulfide bonds (DSBs)—covalent linkages between cysteine residues—form and function in bacterial proteins. The research employs two model organisms, Escherichia coli and Mycobacterium smegmatis, to address three principal research questions: the principles enabling productive thiol oxidation when canonical DSB-forming enzymes are inactive; the identity of proteins dependent on DSBs in complex cell envelopes; and whether distinct thiol-disulfide oxidoreductases demonstrate substrate specificity. The research program utilizes a multidisciplinary approach combining bacterial genetics, chemical genetics, and biochemistry to advance understanding of DSB formation mechanisms and reveal novel oxidation pathways. The work will characterize substrate recognition determinants among different oxidoreductase classes and elucidate how DSB-forming pathways function across diverse bacterial systems. Research activities are conducted at Indiana University's Bloomington, Indiana campus, with expected completion in February 2031.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $415.8k | 3/13/26 |